Company: XTIA
Filing Date: 2025-06-03
Form Type: DRS
Source: 0001213900-25-050156
Chunk: 6

Company: XTI Aerospace, Inc.
Filing Date: 2025-06-03
Form: DRS
Chunk 6
---
 2023 and amended on December 30, 2023 and March 12, 2024 (as so amended, the
“XTI Merger Agreement”), whereby Merger Sub merged with and into Legacy XTI with Legacy XTI surviving the merger as a wholly-owned
subsidiary of XTI Aerospace, Inc. (the “XTI Merger”). In connection with the closing of the XTI Merger, we changed our corporate
name to “XTI Aerospace, Inc.”

Except as otherwise indicated
herein or as the context otherwise requires, references in this prospectus and the information incorporated by referenced herein to “XTI
Aerospace,” the “Company,” “we,” “us,” “our” and similar terms refer collectively
to XTI Aerospace, Inc. and our subsidiaries, Inpixon GmbH, Inpixon Holding UK Limited, IntraNav GmbH, and prior to the closing of the
XTI Merger, Merger Sub, and after the closing of the XTI Merger, Legacy XTI.

<div align='center'>Note Regarding Reverse Stock Splits</div>

We effected a reverse stock
split of our outstanding common stock at a ratio of 1-for-100, effective as of March 12, 2024, for the purpose of complying with Nasdaq
Listing Rule 5550(a)(2) and satisfying the bid price requirements applicable for initial listing applications in connection with the closing
of the XTI Merger. We also effected a reverse stock split of our outstanding common stock at a ratio of 1-for-250, effective as of January
10, 2025, for the purpose of complying with Nasdaq Listing Rule 5550(a)(2). We have reflected the reverse stock splits herein, unless
otherwise indicated.

<div align='center'>ii

PROSPECTUS SUMMARY</div>

The following summary highlights information contained or incorporated by reference elsewhere in this prospectus and does not contain all of the information that you should consider in making your investment decision. Before investing in our common stock, you should carefully read this entire prospectus, including our consolidated financial statements and the related notes and other documents incorporated by reference herein, as well as the information under the caption “Risk Factors” herein and under similar headings in the other documents that are incorporated by reference in this prospectus including documents that are filed after the date hereof. Some of the statements in this prospectus constitute forward-looking statements that involve risks and uncertainties. See “Ca